The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Advanced Drug Delivery Market Research Report 2025
Synopsis
Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
The global Advanced Drug Delivery market was valued at US$ 5228 million in 2023 and is anticipated to reach US$ 17250 million by 2030, witnessing a CAGR of 18.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Advanced Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Drug Delivery.
Report Scope
The Advanced Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Advanced Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Segment by Type
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Segment by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
The global Advanced Drug Delivery market was valued at US$ 5228 million in 2023 and is anticipated to reach US$ 17250 million by 2030, witnessing a CAGR of 18.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Advanced Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Drug Delivery.
Report Scope
The Advanced Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Advanced Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Segment by Type
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Segment by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Polymeric Drug Delivery
1.2.3 Implants & IUD's
1.2.4 Sustained Release
1.2.5 Targeted Drug Delivery
1.2.6 Prodrugs
1.3 Market by Application
1.3.1 Global Advanced Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Surgical Centers/Clinics
1.3.5 Home Care Settings
1.3.6 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Drug Delivery Market Perspective (2019-2030)
2.2 Advanced Drug Delivery Growth Trends by Region
2.2.1 Global Advanced Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Advanced Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Advanced Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Advanced Drug Delivery Market Dynamics
2.3.1 Advanced Drug Delivery Industry Trends
2.3.2 Advanced Drug Delivery Market Drivers
2.3.3 Advanced Drug Delivery Market Challenges
2.3.4 Advanced Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Drug Delivery Players by Revenue
3.1.1 Global Top Advanced Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Advanced Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Advanced Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Advanced Drug Delivery Revenue
3.4 Global Advanced Drug Delivery Market Concentration Ratio
3.4.1 Global Advanced Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Drug Delivery Revenue in 2023
3.5 Advanced Drug Delivery Key Players Head office and Area Served
3.6 Key Players Advanced Drug Delivery Product Solution and Service
3.7 Date of Enter into Advanced Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Drug Delivery Breakdown Data by Type
4.1 Global Advanced Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Advanced Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Advanced Drug Delivery Breakdown Data by Application
5.1 Global Advanced Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Advanced Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Advanced Drug Delivery Market Size (2019-2030)
6.2 North America Advanced Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Advanced Drug Delivery Market Size by Country (2019-2024)
6.4 North America Advanced Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Drug Delivery Market Size (2019-2030)
7.2 Europe Advanced Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Advanced Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Advanced Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Advanced Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Advanced Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Advanced Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Drug Delivery Market Size (2019-2030)
9.2 Latin America Advanced Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Advanced Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Advanced Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Advanced Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Advanced Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Advanced Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co
11.1.1 Merck & Co Company Detail
11.1.2 Merck & Co Business Overview
11.1.3 Merck & Co Advanced Drug Delivery Introduction
11.1.4 Merck & Co Revenue in Advanced Drug Delivery Business (2019-2024)
11.1.5 Merck & Co Recent Development
11.2 Antares Pharma
11.2.1 Antares Pharma Company Detail
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Advanced Drug Delivery Introduction
11.2.4 Antares Pharma Revenue in Advanced Drug Delivery Business (2019-2024)
11.2.5 Antares Pharma Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Advanced Drug Delivery Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Advanced Drug Delivery Introduction
11.4.4 Novartis Revenue in Advanced Drug Delivery Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Advanced Drug Delivery Introduction
11.5.4 Bayer Revenue in Advanced Drug Delivery Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Advanced Drug Delivery Introduction
11.6.4 Sanofi Revenue in Advanced Drug Delivery Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Company Detail
11.7.2 Glaxosmithkline Business Overview
11.7.3 Glaxosmithkline Advanced Drug Delivery Introduction
11.7.4 Glaxosmithkline Revenue in Advanced Drug Delivery Business (2019-2024)
11.7.5 Glaxosmithkline Recent Development
11.8 3M
11.8.1 3M Company Detail
11.8.2 3M Business Overview
11.8.3 3M Advanced Drug Delivery Introduction
11.8.4 3M Revenue in Advanced Drug Delivery Business (2019-2024)
11.8.5 3M Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Advanced Drug Delivery Introduction
11.9.4 Pfizer Revenue in Advanced Drug Delivery Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Advanced Drug Delivery Introduction
11.10.4 Johnson & Johnson Revenue in Advanced Drug Delivery Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Detail
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Advanced Drug Delivery Introduction
11.11.4 Abbott Laboratories Revenue in Advanced Drug Delivery Business (2019-2024)
11.11.5 Abbott Laboratories Recent Development
11.12 Allergan
11.12.1 Allergan Company Detail
11.12.2 Allergan Business Overview
11.12.3 Allergan Advanced Drug Delivery Introduction
11.12.4 Allergan Revenue in Advanced Drug Delivery Business (2019-2024)
11.12.5 Allergan Recent Development
11.13 Baxter International
11.13.1 Baxter International Company Detail
11.13.2 Baxter International Business Overview
11.13.3 Baxter International Advanced Drug Delivery Introduction
11.13.4 Baxter International Revenue in Advanced Drug Delivery Business (2019-2024)
11.13.5 Baxter International Recent Development
11.14 Mylan Pharmaceutical
11.14.1 Mylan Pharmaceutical Company Detail
11.14.2 Mylan Pharmaceutical Business Overview
11.14.3 Mylan Pharmaceutical Advanced Drug Delivery Introduction
11.14.4 Mylan Pharmaceutical Revenue in Advanced Drug Delivery Business (2019-2024)
11.14.5 Mylan Pharmaceutical Recent Development
11.15 Roche Holding
11.15.1 Roche Holding Company Detail
11.15.2 Roche Holding Business Overview
11.15.3 Roche Holding Advanced Drug Delivery Introduction
11.15.4 Roche Holding Revenue in Advanced Drug Delivery Business (2019-2024)
11.15.5 Roche Holding Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
